Literature DB >> 9632133

Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade.

S M Oldham1, A D Cox, E R Reynolds, N S Sizemore, R J Coffey, C J Der.   

Abstract

Src transformation of NIH3T3 mouse fibroblasts has been shown to be dependent on Ras function. Since we recently showed that the signaling pathways that mediate Ras transformation of RIE-1 rat intestinal epithelial cells are distinct from those that cause Ras transformation of fibroblasts, we utilized three approaches to determine if Src transformation of RIE-1 cells is dependent on Ras. First, although both Ras and Src cause upregulation of an epidermal growth factor (EGF) receptor-dependent autocrine growth loop, only Ras transformation required this activity. Second, whereas both Src and Ras caused upregulation of the p42 and p44 mitogen-activated protein kinases (MAPKs), only Ras transformation was blocked by the inhibition of MAPK activation by treatment with the PD 98059 MEK inhibitor. Third, treatment with the farnesyltransferase inhibitor FTI-277 blocked Ras, but not Src, transformation. Taken together, these observations suggest that Src transformation of RIE-1 cells is not dependent on Ras. Finally, we determined that Ras activation of Raf-independent pathways alone is sufficient to cause growth transformation of RIE-1 cells. Thus, both Ras and Src cause transformation of RIE-1 cells via pathways distinct from those required to cause transformation of NIH3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632133     DOI: 10.1038/sj.onc.1201784

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Authors:  Janiel M Shields; Heena Mehta; Kevin Pruitt; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer.

Authors:  V Stoll; V Calleja; G Vassaux; J Downward; N R Lemoine
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells.

Authors:  K R LaMontagne; M A Moses; D Wiederschain; S Mahajan; J Holden; H Ghazizadeh; D A Frank; J L Arbiser
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.

Authors:  A McFall; A Ulkü; Q T Lambert; A Kusa; K Rogers-Graham; C J Der
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways.

Authors:  E Penuel; G S Martin
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

6.  The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties.

Authors:  X Qian; L Esteban; W C Vass; C Upadhyaya; A G Papageorge; K Yienger; J M Ward; D R Lowy; E Santos
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

7.  Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1.

Authors:  Jidong Zhu; John Blenis; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-01       Impact factor: 11.205

8.  Src transformation of colonic epithelial cells: enhanced anchorage-independent growth in an Apc(+/min) background.

Authors:  Sabata S Constancio-Lund; Jan Brabek; Steven K Hanks
Journal:  Mol Carcinog       Date:  2009-02       Impact factor: 4.784

9.  Pro-neoplastic effects of amphiregulin in colorectal carcinogenesis.

Authors:  Michael J Guzman; Jinyi Shao; Hongmiao Sheng
Journal:  J Gastrointest Cancer       Date:  2013-06

10.  Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia.

Authors:  K C Ray; M E Moss; J L Franklin; C J Weaver; J Higginbotham; Y Song; F L Revetta; S A Blaine; L R Bridges; K E Guess; R J Coffey; H C Crawford; M K Washington; A L Means
Journal:  Oncogene       Date:  2013-02-04       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.